Method for treating hepatitis C virus with omega interferon

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7727519
APP PUB NO 20050201980A1
SERIAL NO

10982532

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods for the treatment of interferon-response disorders by administration of an interferon alone or in combination with adjunctive therapy are described. The invention encompasses providing to a patient both a formulation of an interferon that is suitable for short-term administration and a formulation of an interferon associated with a sustained release delivery system that is suitable for long-term administration. A principal advantage of the method is that responsiveness to treatment can be ascertained with short-term dosimetric techniques using one formulation of an interferon, which permits the appropriate selection of a dose that is both effective and safe for long-term administration using the second formulation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INTARCIA THERAPEUTICS INCONE MARIANA PARK DRIVE SUITE 1300 BOSTON MA 02110

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Moran, Mark Stanford Orinda, US 2 34

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation